Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140

NCT02483078 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV

Interventions

DRUG: PRO 140
DRUG: Placebo
DRUG: Optimized Background Regimen

Sponsor

CytoDyn, Inc.